Peter G. Thomson is VP Finance & Accounting of Fulcrum Therapeutics, Inc.. Currently has a direct ownership of 15,212 shares of FULC, which is worth approximately $49,286. The most recent transaction as insider was on Feb 22, 2021, when has been sold 5,000 shares (Common Stock) at a price of $14.72 per share, resulting in proceeds of $73,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.2K
0% 3M change
0% 12M change
Total Value Held $49,286

Peter G. Thomson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 22 2021
SELL
Open market or private sale
$73,600 $14.72 p/Share
5,000 Reduced 24.74%
15,212 Common Stock
Feb 22 2021
BUY
Exercise of conversion of derivative security
$39,200 $7.84 p/Share
5,000 Added 19.83%
20,212 Common Stock
Jan 21 2021
SELL
Open market or private sale
$92,498 $14.0 p/Share
6,607 Reduced 30.28%
15,212 Common Stock
PGT

Peter G. Thomson

VP Finance & Accounting
Cambridge, MA

Track Institutional and Insider Activities on FULC

Follow Fulcrum Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FULC shares.

Notify only if

Insider Trading

Get notified when an Fulcrum Therapeutics, Inc. insider buys or sells FULC shares.

Notify only if

News

Receive news related to Fulcrum Therapeutics, Inc.

Track Activities on FULC